A Phase 2 Trial Testing ZP1848 in Patients With SBS
Phase of Trial: Phase II
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Glepaglutide (Primary)
- Indications Short bowel syndrome
- Focus Proof of concept; Therapeutic Use
- Sponsors Zealand Pharma
- 19 Jun 2017 Results published in a Zealand Pharma media release.
- 19 Jun 2017 Primary endpoint (wet weight of ostomy output or diarrhea) has been met according to a Zealand Pharma media release.
- 17 May 2017 According to a Zealand Pharma media release, results are expected by end June 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History